Pateclizumab (MLTA3698A) is an immunomodulator. It binds to

lymphotoxin alpha Lymphotoxin-alpha (LT-α) formerly known as tumor necrosis factor-beta (TNF-β) is a protein that in humans is encoded by the ''LTA'' gene. Belonging to the hematopoietic cell line, LT-α exhibits anti-proliferative activity and causes the cellu ...

. This drug was developed by

Genentech Genentech, Inc. is an American biotechnology corporation headquartered in South San Francisco, California. It operates as an independent subsidiary of holding company Roche. Genentech Research and Early Development operates as an independent cent ...

Roche F. Hoffmann-La Roche AG, commonly known as Roche (), is a Switzerland, Swiss multinational corporation, multinational holding healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics. Its holding company, ...

References

Monoclonal antibodies {{antineoplastic-drug-stub